China: Landmark trade deal could spare South Korean firms from antitrust troubles
A landmark trade agreement inked between China and South Korea would classify South Korean companies as domestic companies, granting them “national treatment” that could spare the firms from harsh antitrust treatment as a foreign entity.
According to reports, while exact terms of the agreement are still pending on both sides, the deal could include a provision regarding due process and appeals in antitrust investigations regarding South Korean companies. Reports say such benefits could offer a great advantage to the companies as criticism mounts over Chinese competition authorities’ allegedly unfair treatment towards foreign companies.
South Korea would be the first nation to gain such rights in China, reports say.
South Korea previously gained antitrust provisions in a trade agreement with the US; the 2007 deal offered “robust procedural protections” for antitrust matters to South Korean companies.
Full content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Senate Democrats Urge DOJ Investigation into Alleged Big Oil Collusion
May 30, 2024 by
CPI
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI